Fidson Healthcare Plc recently published its Unaudited Financial Statement for the year ended 31 December 2024. The result showed significant growth in the Company’s revenue and profit after tax, year on year.
Revenue of N84.189 billion was reported for the 12 months period, up by 58.70% from N53.05 billion reported the previous year.
Profit after tax of N5.05 billion was achieved for the 12 months period, up by 39.91% from N3.61 billion reported the previous year.
Earnings per share of Fidson stands at N2.20.
At the share price of N17, the P/E ratio of Fidson Healthcare stands at 7.73x with earnings yield of 12.94%.
Fidson Healthcare Plc grows revenue by 58.7% in Q4 2024, profit hits N5.05bn
Fidson Healthcare Plc recently published its Unaudited Financial Statement for the year ended 31 December 2024. The result showed significant growth in the Company’s revenue and profit after tax, year on year.
Revenue of N84.189 billion was reported for the 12 months period, up by 58.70% from N53.05 billion reported the previous year.
Profit after tax of N5.05 billion was achieved for the 12 months period, up by 39.91% from N3.61 billion reported the previous year.
Earnings per share of Fidson stands at N2.20.
At the share price of N17, the P/E ratio of Fidson Healthcare stands at 7.73x with earnings yield of 12.94%.
The company earnings has been very stable in the last two years, investors with long term vision can hold: P/E ratio of 7.73 is very very ok: then watch price come down below #17 and buy more so that can cash out dividend and capital gains.
This equity remains investors taste for the rest of the year 2025.